Retatrutide NNT: How Effective Is It Really?
Number Needed to Treat (NNT) cuts through the hype to show how likely you are to benefit. Retatrutide's NNT is among the lowest in all of medicine.
Retatrutide's NNT (Number Needed to Treat) tells a remarkable story about the drug's effectiveness. While average weight loss of 24.2% is impressive, NNT answers a more practical question: if I take this drug, how likely am I to see meaningful results? Based on Phase 2 data (Jastreboff et al., NEJM 2023), the answer is: almost certain. Retatrutide's NNT for clinically significant weight loss is approximately 1.2-1.3, meaning virtually every patient achieves the target outcome. This is extraordinary in pharmaceutical medicine.
Data Note
NNT calculations below use Phase 2 data. Phase 3 trials will provide more definitive numbers. NNTs are approximations based on published responder rates.
What NNT Means in Plain Language
NNT answers: "How many people do I need to treat with this drug for one person to achieve a specific result who would not have achieved it otherwise?" The calculation is simple:
NNT = 1 / (drug response rate - placebo response rate)
A perfect drug would have an NNT of 1 (every single patient benefits). Most medications have NNTs of 5-20 or higher. An NNT below 2 is considered remarkably effective.
Retatrutide's NNT at 12 mg
Retatrutide NNT by Weight Loss Threshold
| Outcome | Drug Rate | Placebo Rate | NNT | Interpretation |
|---|---|---|---|---|
| 5%+ loss | ~100% | ~30% | ~1.4 | Nearly universal response |
| 10%+ loss | ~93% | ~10% | ~1.2 | Exceptional |
| 15%+ loss | ~83% | ~3% | ~1.25 | Exceptional |
| 20%+ loss | ~63% | ~1% | ~1.6 | Very strong |
| 25%+ loss | ~54% | ~0% | ~1.85 | Strong |
NNT Comparison Across Drugs
| Drug | NNT for 10%+ loss | NNT for 15%+ loss | NNT for 20%+ loss |
|---|---|---|---|
| Semaglutide 2.4 mg | ~1.5 | ~2.0 | ~3.5 |
| Tirzepatide 15 mg | ~1.3 | ~1.5 | ~1.8 |
| Retatrutide 12 mg | ~1.2 | ~1.25 | ~1.6 |
Approximate NNTs from published trial data. Cross-trial comparisons have limitations.
Retatrutide has the lowest NNT across all thresholds, confirming it is the most consistently effective weight loss drug ever tested. But even semaglutide and tirzepatide have impressively low NNTs — all three are remarkably effective medications.
NNT in Medical Context
To appreciate how good these NNTs are, consider other common medications:
- Statins for preventing heart attack: NNT of ~50-100 over 5 years
- Blood pressure medications: NNT of ~15-20 for preventing cardiovascular events
- Aspirin for heart attack prevention: NNT of ~100+
- Retatrutide for 15%+ weight loss: NNT of ~1.25
Retatrutide's NNT is orders of magnitude better than medications we routinely prescribe for chronic disease prevention. This reflects how reliably the triple-agonist mechanism produces weight loss across the patient population.
Highly Effective Treatments Available Now
Both semaglutide and tirzepatide have impressive NNTs and are available today:
- Compounded semaglutide: $125/month
- Compounded tirzepatide: $125/month
Learn more about how to get started.
Medical Disclaimer
Retatrutide is an investigational drug not FDA-approved. NNT calculations are approximations based on Phase 2 data (Jastreboff et al., NEJM 2023). Individual results vary. Consult your healthcare provider about weight loss treatment options.
Proven Effectiveness Available Today
Semaglutide and tirzepatide have remarkably low NNTs too. Start from $99/mo.
Get Started TodayMore on triumph trials
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).